CIK 0002044725 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Evommune, Inc.
Sign in to watch- Ticker
- EVMN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850742575
- Phone
- (650) 223-7745
- Business address
- 1891 PAGE MILL RD, PALO ALTO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-01 | Pena Luis C. President & CEO | Sale 10b5-1 | −16,787 | $22.74 | $382K | 637,896 |
| 2026-05-28 | Carver Kyle Chief Financial Officer | Option exercise 10b5-1 | +15,000 | $2.99 | $45K | 77,510 |
| 2026-05-28 | Carver Kyle Chief Financial Officer | Sale 10b5-1 | −18,175 | $22.84 | $415K | 59,335 |
| 2026-05-28 | Carver Kyle Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −15,000 | 96,731 | ||
| 2026-05-28 | Moss Gregory S. Chief Business & Legal Officer | Option exercise 10b5-1 | +14,223 | $1.71 | $24K | 75,058 |
| 2026-05-28 | Moss Gregory S. Chief Business & Legal Officer | Sale 10b5-1 | −14,223 | $22.83 | $325K | 60,835 |
| 2026-05-28 | Moss Gregory S. Chief Business & Legal Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −14,223 | 47,845 | ||
| 2026-04-16 | Patel Jeegar Pravinkumar Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +69,315 | 69,315 | ||
| 2026-04-16 | Drew Janice Suzann Chief of Dev. Operations | Grant or award · Employee Stock Option (Right to Buy) | +73,892 | 73,892 | ||
| 2026-04-16 | Carver Kyle Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +98,946 | 98,946 | ||
| 2026-04-16 | Moss Gregory S. Chief Business & Legal Officer | Grant or award · Employee Stock Option (Right to Buy) | +115,279 | 115,279 | ||
| 2026-04-16 | Bauer Eugene Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +51,117 | 51,117 | ||
| 2026-04-16 | Pena Luis C. President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +291,420 | 291,420 | ||
| 2026-02-17 | LSP 7 Cooperative UA Director | Grant or award | +358,680 | $27.88 | $10.0M | 5,288,313 |
| 2026-02-17 | Verduyn-van Weegen Felice Isabel Director | Grant or award | +358,680 | $27.88 | $10.0M | 5,288,313 |
| 2026-02-17 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +35,868 | $27.88 | $1000K | 2,710,293 |
| 2025-12-19 | Hopfner Robert Lorne Director | Purchase | +1,000 | $17.35 | $17K | 4,026 |
| 2025-12-09 | Patel Jeegar Pravinkumar Chief Scientific Officer | Shares withheld for taxes | −7,513 | $17.84 | $134K | 49,578 |
| 2025-12-09 | Drew Janice Suzann EVP, Operations | Shares withheld for taxes | −5,074 | $17.84 | $91K | 67,794 |
| 2025-12-09 | Carver Kyle Chief Financial Officer | Shares withheld for taxes | −13,290 | $17.84 | $237K | 62,510 |
Page 2 of 6 · 109 trades